Obermatt

Alcon

VTX:ALC · CH0432492467
Health Care Equipment & SuppliesX-Large

360

51
EV / EBIT43
Price / Owner Earnings22
Owner Earnings Yield59
Dividend Yield41
Price/Sales37
EV / Gross Profit30
Price/Book84
Return on Capital43
Cash Return on Capital56
Return on Equity45
EBIT Margin61
Gross Profitability30
Cash Conversion73
Accruals50
Owner Earnings Margin79
Sales growth70
Profit Growth92
Long-Term EPS Growth71
Owner Earnings Growth25
Reinvestment81
Price momentum19
Debt load71
Refinancing78
Debt Payback52
Liquidity52
Analyst ratings76
Opinion Changes50
Price Target Upside84
Market mood89
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Alcon clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeX-Large
TypePublic Company
ExchangeSWX
Founded1947
Employees17,687
Websitealcon.ch
ISINCH0432492467
Last UpdateApr 2, 2026
Themes
Utility Scale SolarBiomedical EngineeringHealth DiagnosticsOphthalmologyDetectors, Sensors and MemsSurgeryHealth CareManufacturingMedical Device

Description

Alcon Inc. (Alcon) researches, develops, manufactures, distributes, and sells a full suite of eye care products. The company is operating in 56 countries and serves consumers and patients in over 140 countries and territories. The company has two se…

Analysis

Middle-of-the-road

Alcon Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 25.2× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 9% yearly growth; analysts expect 12%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is adequate. The company scores 8/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
100
2023202420252026

All-time high

100

Jun 2026

All-time low

25

Jan 2024

Average rank

64

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
37
13
28
31
Price/Earnings
37
28
35
29
Price/Book
84
61
70
84
Dividend Yield
41
35
36
28
Value (overall)
53
36
39
29

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Alcon with its peers
Medtronic
NYQ:MDT
70
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Spire
LSE:SPI
38
CountryUK
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Carl Zeiss Meditec
GER:AFX
50
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
EssilorLuxottica
PAR:EL
55
CountryFrance
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
InMode
NSQ:INMD
86
CountryIsrael
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Nel ASA
OSL:NEL
6
CountryGermany
IndustryElectrical Equipment
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →